Dartmouth-Hitchcock Obligated Group is part of the parent organization Dartmouth-Hitchcock Health.
“The CreditWatch placement reflects our view of Dartmouth-Hitchcock’s recent release of unaudited fourth quarter financial statements (period ended June 30, 2016), which included a significant operating loss compared to our expectations for the fiscal year,” said S&P analyst Jennifer Soule.
“It also reflects the unexpected departure of Dartmouth-Hitchcock’s CFO and uncertainties about the system’s ability to re-stabilize its financial performance in fiscal 2017 following financial challenges it experienced implementing a new billing system during fiscal 2016,” Ms. Soule added.
Dartmouth-Hitchcock named Daniel Jantzen CFO in July. He replaced Robin Kilfeather-Mackey.
More articles on healthcare finance:
From money pit to strategy unit: ClearBalance CEO talks change in RCM
Fitch affirms Kings’ Daughters’ Health’s ‘BBB+’ rating
Oregon’s healthcare price transparency grade improves after website creation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
